Detalhe da pesquisa
1.
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
N Engl J Med
; 385(13): 1172-1183, 2021 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34192426
2.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33951374
3.
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis
; 76(3): 398-407, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36210481
4.
Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution.
Mol Pharm
; 18(1): 359-376, 2021 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33322901
5.
Maternal immunization: opportunities for scientific advancement.
Clin Infect Dis
; 59 Suppl 7: S408-14, 2014 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25425719
6.
A Pseudovirus-Based Neutralization Assay for SARS-CoV-2 Variants: A Rapid, Cost-Effective, BSL-2-Based High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 12(3)2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38543552
7.
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy Trial.
Open Forum Infect Dis
; 10(1): ofac693, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36655191
8.
Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation.
Microorganisms
; 11(2)2023 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36838333
9.
A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection.
Microorganisms
; 11(7)2023 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37512961
10.
Immunogenicity and protection of a variant nanoparticle vaccine that confers broad neutralization against SARS-CoV-2 variants.
Nat Commun
; 14(1): 1130, 2023 02 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36854666
11.
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.
Sci Immunol
; 8(88): eadg7015, 2023 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-37191508
12.
Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates.
Vaccines (Basel)
; 10(8)2022 Aug 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36016226
13.
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial.
Lancet Respir Med
; 10(2): 167-179, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34800364
14.
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial.
Lancet HIV
; 9(5): e309-e322, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35489376
15.
Role of urea and melamine as synergic co-plasticizers for starch composites for fertilizer application.
Int J Biol Macromol
; 144: 143-150, 2020 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31843606
16.
Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity.
Vaccines (Basel)
; 8(4)2020 Oct 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33066540
17.
Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge.
Vaccine
; 38(5): 1258-1270, 2020 01 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31761502
18.
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
Science
; 370(6520): 1089-1094, 2020 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-33082295
19.
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
bioRxiv
; 2020 Aug 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32793901
20.
Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
Vaccine
; 37(42): 6134-6138, 2019 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31492474